HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+23.75%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
(-86%)
Cap. Flow
-$719M
Cap. Flow
% of AUM
-658.8%
Top 10 Holdings %
Top 10 Hldgs %
91.26%
Holding
65
New
6
Increased
2
Reduced
11
Closed
43
Top Buys
| 1 |
DexCom
DXCM
|
$7.69M |
| 2 |
Acrivon Therapeutics
ACRV
|
$3.27M |
| 3 |
CONMED
CNMD
|
$2.44M |
| 4 |
Intuitive Surgical
ISRG
|
$1.53M |
| 5 |
Penumbra
PEN
|
$1.11M |
Top Sells
| 1 |
AbbVie
ABBV
|
$41.6M |
| 2 |
Agilent Technologies
A
|
$41.1M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$40.5M |
| 4 |
Boston Scientific
BSX
|
$37.1M |
| 5 |
Eli Lilly
LLY
|
$33.4M |
Sector Composition
| 1 | Healthcare | 99.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
26
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-85,230
| Closed | -$1.53M |
|
|
CANO
27
DELISTED
Cano Health, Inc.
CANO
| – | – |
-395,560
| Closed | -$3.43M |
|
|
SGEN
28
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-57,340
| Closed | -$7.85M |
|
|
SWAV
29
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-19,720
| Closed | -$5.48M |
|
|
RVNC
30
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-64,590
| Closed | -$1.74M |
|
|
NVRO
31
DELISTED
NEVRO CORP.
NVRO
| – | – |
-67,600
| Closed | -$3.15M |
|
32
Dentsply Sirona
XRAY
$2.77B
| – | – |
-158,200
| Closed | -$4.49M |
|
33
UnitedHealth
UNH
$279B
| – | – |
-62,980
| Closed | -$31.8M |
|
34
Thermo Fisher Scientific
TMO
$183B
| – | – |
-51,240
| Closed | -$26M |
|
35
Tenet Healthcare
THC
$16.5B
| – | – |
-518,990
| Closed | -$26.8M |
|
36
Natera
NTRA
$23B
| – | – |
-65,130
| Closed | -$2.85M |
|
37
NeoGenomics
NEO
$1.06B
| – | – |
-391,110
| Closed | -$3.37M |
|
38
Merus
MRUS
$5.04B
| – | – |
-272,890
| Closed | -$5.47M |
|
39
Molina Healthcare
MOH
$9.6B
| – | – |
-27,540
| Closed | -$9.08M |
|
40
McKesson
MCK
$85.9B
| – | – |
-35,040
| Closed | -$11.9M |
|
41
Leap Therapeutics
LPTX
$12M
| – | – |
-1,066,689
| Closed | -$939K |
|
|
42
Eli Lilly
LLY
$661B
| – | – |
-103,150
| Closed | -$33.4M |
|
43
LivaNova
LIVN
$3.09B
| – | – |
-328,030
| Closed | -$16.7M |
|
44
Kezar Life Sciences
KZR
$28.5M
| – | – |
-1,607,650
| Closed | -$13.8M |
|
45
Incyte
INCY
$17B
| – | – |
-227,851
| Closed | -$15.2M |
|
|
IMA
46
ImageneBio, Inc. Common Stock
IMA
$153M
| – | – |
-220,082
| Closed | -$781K |
|
47
Humana
HUM
$37.5B
| – | – |
-42,920
| Closed | -$20.8M |
|
48
Henry Schein
HSIC
$8.14B
| – | – |
-248,920
| Closed | -$16.4M |
|
49
Hologic
HOLX
$14.7B
| – | – |
-137,330
| Closed | -$8.86M |
|
50
Elevance Health
ELV
$72.4B
| – | – |
-38,910
| Closed | -$17.7M |
|